ARN-Trio Registry Highlights Major Shifts in Infliximab Biosimilar Use
Analysis of the American Rheumatology Network-Trio Health (ARN-Trio) registry finds a surge in new prescriptions for Merck’s Renflexis infliximab biosimilar. The ARN-Trio registry is the